Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/65597
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to colon carcinoma cell lines and polymorphonuclear cells |
Autor: | Dianzani, Chiara; Minelli, Rosalba; Mesturini, Riccardo; Chiocchetti, Annalisa; Barrera, Giuseppina; Boscolo, Sabrina; Sarasso, Chiara; Gigliotti, Casimiro Luca; Sblattero, Daniele; Yagi, Junji; Rojo, José María CSIC ORCID CVN ; Fantozzi, Roberto; Dianzani, Umberto | Fecha de publicación: | 1-oct-2010 | Editor: | American Association of Immunologists | Citación: | Journal of Immunology 185(7):3970-3979(2010) | Resumen: | Vascular endothelial cells (ECs) are key players in leukocyte recruitment into tissues and metastatic dissemination of tumor cells. ECs express B7h, which is the ligand of the ICOS T cell costimulatory molecule. The aim of this work was to assess the effect of B7h triggering by a soluble form of ICOS (ICOS-Fc) on the adhesion of colon carcinoma cell lines to HUVECs. We found that B7h triggering inhibited HUVEC adhesiveness to HT29 and DLD1 cells (by 50 and 35%, respectively) but not to HCT116 cells. The effect was dependent on the ICOS-Fc dose and was detectable as early as 30 min after treatment and was still present after 24 h. It was inhibited by soluble anti-ICOS reagents (mAb and B7h-Fc) and silencing of B7h on HUVECs, and it was not displayed by an F119S mutated form of ICOS-Fc that does not bind B7h. HUVEC treatment with ICOS-Fc did not modulate expression of adhesion molecules and cytokines, but it substantially downmodulated ERK phosphorylation induced by E-selectin triggering or osteopontin, which may influence HUVEC adhesiveness. Moreover, HUVEC treatment with ICOS-Fc also inhibited adhesion of polymorphonuclear cells and several tumor cell lines from different origins. Therefore, the B7h–ICOS interaction may modulate spreading of cancer metastases and recruitment of polymorphonuclear cells in inflammatory sites, which opens a view on the use of ICOS-Fc as an immunomodulatory drug | Descripción: | 10 páginas, 10 figuras, 1 tabla -- PAGS nros. 3970-3979 | Versión del editor: | http://dx.doi.org/ 10.4049/jimmunol.0903269 | URI: | http://hdl.handle.net/10261/65597 | DOI: | 10.4049/jimmunol.0903269 | ISSN: | 0022-1767 | E-ISSN: | 1550-6606 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
restringido.pdf | 21,67 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
30
checked on 24-abr-2024
WEB OF SCIENCETM
Citations
27
checked on 29-feb-2024
Page view(s)
383
checked on 05-may-2024
Download(s)
157
checked on 05-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.